Impact of MRD Eradication on Survival Outcomes in CLL Patients with Different IGHV Mutation Status

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2019)

引用 0|浏览11
暂无评分
摘要
MRD eradication and IGHV-status could be considered prognostic factors for overall (OS) and progression-free survival (PFS) in CLL patients.
更多
查看译文
关键词
CLL,BR,IGHV-status,MRD,chronic lymphocytic leukemia
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要